Advertisement

Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81
Financing › Details

Mosa Meat–Merck (DE): investment, 201807 financing round Series A totalling €7.5m incl co-lead investor M Ventures

 

Period Period 2018-07-17
  Successor Mosa Meat–Merck (DE): investment, 202009 financing round Series B 1st closing totalling $55m incl existing + co-investor M Ventures
Organisations Money taker Mosa Meat B.V.
  Money source M Ventures (Merck Ventures B.V., MV)
  Group Merck (DE) (Group)
Products Product meat, cultured / clean
  Product 2 venture capital
Index term Index term Mosa Meat–SEVERAL: investment, 201807 financing round Series A €7.5m co-led by M Ventures + Bell Food Group
Person Person Hoffmann, Alexander (Merck (DE) 201807 Principal at M Ventures)
     

Mosa Meat B.V.. (7/17/18). "Press Release: Mosa Meat Raises €7.5m to Commercialise Cultured Meat". Maastricht.

Series A fundraising sees first investment in the field by the corporate venture capital of a leading science and technology company, and funding from Switzerland’s largest meat producer.


Mosa Meat, a spin off company from Maastricht University, today announced that it has raised €7.5M to bring cultured meat to market by 2021. The Dutch start-up has led the cultured meat industry since presenting the world’s first beef burger made directly from cow cells in 2013. This is the first investment in a European cultured meat company, putting Europe on the map for the next generation of meat production.

The round was co-led by M Ventures, the corporate venture capital arm of science and technology company Merck, and Bell Food Group, the leading meat processor in Switzerland with operations across Europe. They are joined by mission-based investors, including the Glass Wall Syndicate.

Mosa Meat was co-founded by Prof Mark Post, the world’s leading scientist in the field who created the first cultured hamburger in 2013. Early investors include Google’s Sergey Brin.

Mosa Meat will use the Series A funding to develop an end-to-end process for cultured meat production at significantly reduced cost.The endpoint of the funding will allow the company to prepare for the construction of a pilot production plant for the introduction of a premium product in 2021.

“We are delighted to join forces with M Ventures and Bell Food Group to create the future of meat,” said Mosa Meat CEO Peter Verstrate. “M Ventures brings strong experience in early-stage financing of science-based companies like ours and has added tremendous value throughout the fundraising process, while Bell Food Group brings strong downstream capabilities in meat processing and distribution. We think this is a perfect collaboration.”

“M Ventures, being the corporate venture capital fund of Merck, is the perfect door-opener to Merck’s deep expertisein culturing cells and producing high quality and scalable cell media. This is significant given that the cell media currently comprises 80% of the cost of cultured meat,” he added.

“Replacing traditional meat production with cultured meat would have a huge impact on the reduction of greenhouse gas emissions, it would free up a large amount of resources that are now used for meat production worldwide and will completely disrupt an old-established and currently unsustainable industry,” said Alexander Hoffmann, Principal at M Ventures. “We’re incredibly excited to be leading this investment into Mosa Meat, a company at the unique cross-section of food and biotech”.

“Meat demand is soaring and in future won’t be met by livestock agriculture alone,” said Lorenz Wyss, CEO of Bell Food Group. We believe this technology can become a true alternative for environment-conscious consumers, and we are delighted to bring our know-how and expertise of the meat business into this strategic partnership with Mosa Meat.”


ABOUT MOSA MEAT

Mosa Meat is a Maastricht-based company developing “cultured meat” – that is, real meat grown from cells rather than slaughtering animals. The team, including Chief Scientific Officer Professor Mark Post, created the world’s first cultured hamburger, inspiring the emergence of a completely new industry. Having proven the concept, Mosa Meatis now developing the first commercial products. The company’s mission is to revolutionise the way we make meat so we can match soaring global demand for meat with production that is sustainable and better for the environment.

www.mosameat.com


ABOUT M VENTURES

M Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck’s core business areas. From our headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. M Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and coinvestors to translate innovation towards commercial success. M Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck’s science and technology base.

www.m-ventures.com


ABOUT BELL FOOD GROUP

The Bell Food Group is one of the leading meat processors and convenience specialists in Europe. Its range of products includes meat, poultry, charcuterie, seafood as well as fresh and non-perishable convenience products. With the brands Bell, Hilcona, Eisberg and Hügli, the Group meets a diversity of customer needs. Its customers include the retail trade as well as the food service sector and the food processing industry. More than 12,000 employees generate annual revenues of around CHF 4 billion. The Bell Food Group is listed on the Swiss stock exchange.

www.bellfoodgroup.com


PRESS CONTACT

For more information and interview requests, please contact:

Sarah Lucas, Press Officer, Mosa Meat
sarah@mosameat.com+44 7828 362 223

   
Record changed: 2020-09-30

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Mosa Meat B.V.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81




» top